# ğŸ§¬ BindX V2 - Drug Discovery Platform

> **Version 9** - Architecture modulaire Project â†’ Campaign â†’ Phase â†’ Run

[![License: MIT](https://img.shields.io/badge/License-MIT-yellow.svg)](https://opensource.org/licenses/MIT)
[![Python 3.10+](https://img.shields.io/badge/Python-3.10+-blue.svg)](https://www.python.org/downloads/)
[![Node.js 18+](https://img.shields.io/badge/Node.js-18+-green.svg)](https://nodejs.org/)
[![Docker](https://img.shields.io/badge/Docker-Required-blue.svg)](https://www.docker.com/)

## ğŸš€ Quick Start (Ubuntu/WSL)

```bash
git clone https://github.com/anthonyboisbouvier-paris/BindX_V2.git
cd BindX_V2
./scripts/dev.sh
```

**PrÃ©requis :** Docker, Docker Compose, Node.js 18+, Python 3.10+

## ğŸ“š Documentation

- ğŸ“‹ [CDC V9 Final](docs/CDC_V9_FINAL.md) - Cahier des charges complet  
- ğŸ—ï¸ [Architecture](docs/ARCHITECTURE.md) - Vue technique  
- ğŸ”„ [Migration V8â†’V9](docs/MIGRATION_V8_TO_V9.md) - Guide migration  
- ğŸ‘¨â€ğŸ’» [Development](docs/DEVELOPMENT.md) - Setup dÃ©veloppement  
- ğŸ¤– [Claude Code](tools/claude/) - Workflows IA  

## ğŸ¯ DiffÃ©rence avec DockIt V8

| Aspect | DockIt V8 | BindX V9 |
|--------|-----------|----------|
| Architecture | Job monolithique | Project â†’ Campaign â†’ Phase â†’ Run |
| Base de donnÃ©es | SQLite | Supabase (PostgreSQL) |
| Runs | 1 job = tout | Runs modulaires (import/calcul/gÃ©nÃ©ration) |
| Interface | Job-centrique | Phase-dashboard centrique |
| Cible | 1 par job | Target Preview + poches multiples |
| Calculs | Bundle fixe | Multi-sÃ©lection (docking+ADMET+scoring...) |

## ğŸ§ª Features V9

### Architecture modulaire
- **Project** : cible thÃ©rapeutique + target preview automatique
- **Campaign** : stratÃ©gie d'exploration (pocket sÃ©lectionnÃ©e)  
- **Phase** : Hit Discovery â†’ Hit-to-Lead â†’ Lead Optimization
- **Run** : unitÃ© atomique (import/calcul/gÃ©nÃ©ration)

### Types de runs
- **Import** : SDF/SMILES, bases connectÃ©es, prÃ©-filtres Lipinski/PAINS
- **Calcul** : multi-sÃ©lection modulaire
  - ğŸ¯ Docking (Vina, GNINA CPU/GPU, DiffDock)
  - ğŸ’Š ADMET (logP, solubility, BBB, hERG, CYP, bioavailability)
  - ğŸ“Š Scoring composite pondÃ©rÃ©
  - ğŸ”— Enrichment (ProLIF interactions, clustering)
  - ğŸ¨ Clustering (diversitÃ©, scaffolds, Tanimoto)
  - âš ï¸ Off-target sÃ©lectivitÃ©  
  - âœ… Confidence (PAINS, applicability domain)
  - âš—ï¸ Retrosynthesis (faisabilitÃ©, coÃ»t, rÃ©actifs)
  - ğŸ›¡ï¸ Safety (hERG, AMES, hepatotox, carcinogenicity)
- **GÃ©nÃ©ration** : de novo REINVENT4 (mode batch + molÃ©cule individuelle)

### Dashboard cumulatif par phase
- **1 molÃ©cule = 1 ligne** dÃ©dupliquÃ©e par SMILES canonique
- **Runs ajoutent des colonnes** progressivement
- **Popups dÃ©taillÃ©es** : safety, synthesis, confidence
- **Viewer 3D intÃ©grÃ©** : drawer 40% + plein Ã©cran, 3Dmol.js
- **Bookmarks & freeze** pour pipeline phase â†’ phase

### Agent IA campagne
- **Cross-phases analysis** : attrition, enrichment factor
- **Recommandations intelligentes** : prochains runs, paramÃ¨tres
- **Safety alerts** : red flags ADMET, scaffold analysis
- **Chat contextuel** avec accÃ¨s toutes les donnÃ©es

## ğŸ› ï¸ Tech Stack

- **Frontend** : React 18, Vite, TailwindCSS, 3Dmol.js, Recharts
- **Backend** : FastAPI, SQLAlchemy, Pydantic V2, Celery, Redis  
- **Database** : Supabase (PostgreSQL + Auth + Storage + RLS)
- **Containers** : Docker, Docker Compose, multi-stage builds
- **Pipeline** : AutoDock Vina, GNINA, GNINA GPU (RunPod), DiffDock
- **Cheminformatics** : RDKit, OpenEye, fpocket, ProLIF, MDAnalysis
- **ML** : REINVENT4, scikit-learn, PyTorch, Transformers
- **Deployment** : Nginx, SSL auto-renewal, domain routing

## ğŸ“¦ Project Structure

```
BindX_V2/
â”œâ”€â”€ docs/                    # ğŸ“š Documentation complÃ¨te
â”œâ”€â”€ backend/                 # ğŸ API FastAPI + pipeline
â”œâ”€â”€ frontend/                # âš›ï¸ Interface React
â”œâ”€â”€ infrastructure/          # ğŸ—ï¸ Docker, Supabase, deploy
â”œâ”€â”€ tools/claude/           # ğŸ¤– Claude Code workflows  
â”œâ”€â”€ scripts/                # ğŸš€ Automation
â””â”€â”€ data/                   # ğŸ“Š Structures, cache (gitignored)
```

## ğŸš€ Development Quickstart

### 1. Environment Setup
```bash
# Clone & setup
git clone https://github.com/anthonyboisbouvier-paris/BindX_V2.git
cd BindX_V2

# Configure environment  
cp .env.example .env
# Edit .env with your Supabase credentials
```

### 2. Docker Development
```bash
# Start all services
./scripts/dev.sh

# Or manually
docker-compose up -d
```

### 3. Access Points
- ğŸŒ **Frontend** : http://localhost:3000
- ğŸ **Backend** : http://localhost:8000  
- ğŸ“š **API Docs** : http://localhost:8000/docs
- ğŸ—„ï¸ **Database** : Supabase Dashboard

### 4. Claude Code Integration
```bash
# AI-powered development
cd ~/BindX_V2
claude

# Available shortcuts (see tools/claude/shortcuts.sh)
bx-dev      # Start development
bx-logs     # View container logs  
bx-test     # Run tests
bx-reset    # Restart containers
```

## ğŸ§¬ Scientific Pipeline

### Supported Calculations
- **Structure Processing** : PDB cleanup, pocket detection (fpocket), validation
- **Molecular Docking** : Vina (CPU), GNINA (CPU/GPU), DiffDock (ML-based)
- **ADMET Prediction** : Solubility, permeability, metabolism, toxicity
- **Drug-likeness** : Lipinski Ro5, QED, PAINS filtering
- **De Novo Generation** : REINVENT4 goal-directed optimization
- **Interaction Analysis** : ProLIF protein-ligand fingerprints
- **Selectivity Screening** : Off-target binding prediction
- **Synthetic Accessibility** : Retrosynthetic route planning

### Validation & Quality
- **Confidence Scoring** : Applicability domain, model uncertainty
- **Safety Profiling** : hERG, AMES, hepatotoxicity, carcinogenicity  
- **PAINS Detection** : Pan-assay interference compounds
- **Structural Alerts** : Reactive/toxic substructures

## ğŸ“Š Data Sources

- **ChEMBL** : Bioactivity data, known targets
- **PubChem** : Chemical structures, properties
- **UniProt** : Protein sequences, annotations
- **PDB** : 3D structures (experimental)
- **AlphaFold** : 3D structures (predicted)
- **DrugBank** : Approved drugs, targets

## ğŸ”— Integration

### Docking Engines
- **AutoDock Vina** : Fast, reliable CPU docking
- **GNINA** : CNN-enhanced scoring (CPU/GPU)
- **DiffDock** : Diffusion model for complex poses

### Cloud Computing  
- **RunPod Serverless** : GPU acceleration (10x speedup)
- **Auto-fallback** : CPU â†’ GPU â†’ Mock for development

### Authentication
- **Supabase Auth** : Email/password, magic links
- **Row Level Security** : Multi-tenant data isolation
- **SSO Ready** : SAML/OAuth2 (V10)

## ğŸ”„ Migration from DockIt V8

BindX V9 is a complete rewrite with **no automatic migration**. See [MIGRATION.md](docs/MIGRATION_V8_TO_V9.md) for:

- Data export strategies
- Workflow mapping V8â†’V9  
- Feature comparison matrix
- Step-by-step migration guide

**Legacy support** : V8 projects accessible in read-only mode at `/legacy`.

## ğŸ¤ Contributing

1. Fork the repository
2. Create feature branch (`git checkout -b feature/amazing-feature`)
3. Commit changes (`git commit -m 'Add amazing feature'`)
4. Push to branch (`git push origin feature/amazing-feature`)
5. Open Pull Request

See [DEVELOPMENT.md](docs/DEVELOPMENT.md) for detailed contributor guide.

## ğŸ“ License

This project is licensed under the MIT License - see the [LICENSE](LICENSE) file for details.

## ğŸ™ Acknowledgments

- **OpenEye Scientific** : OMEGA conformer generation
- **SchrÃ¶dinger** : Molecular modeling inspiration
- **ChEMBL Team** : Bioactivity database
- **RDKit Community** : Cheminformatics toolkit
- **AutoDock Team** : Docking algorithms

## ğŸ“ Support

- ğŸ› **Issues** : GitHub Issues tracker
- ğŸ’¬ **Discussions** : GitHub Discussions  
- ğŸ“– **Documentation** : `/docs` folder
- ğŸ¤– **AI Assistant** : Claude Code integration

---

**ğŸ”¬ Built for computational chemists, by computational chemists.**

**From molecular hypothesis to lead compound in record time.**
